H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Microbiology D-index 61 Citations 15,658 263 World Ranking 1061 National Ranking 457

Overview

What is she best known for?

The fields of study she is best known for:

  • Internal medicine
  • Cancer
  • Gene

Elizabeth J. Phillips mainly focuses on Immunology, Human leukocyte antigen, Abacavir, Internal medicine and Drug. Antigen is the focus of her Immunology research. Elizabeth J. Phillips has included themes like Major histocompatibility complex, Immune system, Allele and Drug Hypersensitivity Syndrome in her Human leukocyte antigen study.

The various areas that Elizabeth J. Phillips examines in her Abacavir study include Hypersensitivity reaction, Toxic epidermal necrolysis, CD8, Reverse-transcriptase inhibitor and Hypersensitivity syndrome. Her Internal medicine study combines topics from a wide range of disciplines, such as Gastroenterology and Ribavirin. Her Drug research includes themes of Pharmacogenomics and Intensive care medicine.

Her most cited work include:

  • HLA-B*5701 Screening for Hypersensitivity to Abacavir (1344 citations)
  • Fulminant Myocarditis with Combination Immune Checkpoint Blockade (826 citations)
  • Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant (387 citations)

What are the main themes of her work throughout her whole career to date?

Her primary scientific interests are in Immunology, Human leukocyte antigen, Internal medicine, Drug and Abacavir. Her Immunology research is multidisciplinary, incorporating perspectives in Pharmacogenetics, Pharmacogenomics and Virology. Her research in Human leukocyte antigen intersects with topics in Typing, Disease, Allele and Genotype.

Her work in Internal medicine tackles topics such as Antibiotics which are related to areas like Allergy. The study incorporates disciplines such as Toxic epidermal necrolysis and Intensive care medicine in addition to Drug. Her biological study spans a wide range of topics, including Nevirapine, Hypersensitivity reaction and Genetic testing.

She most often published in these fields:

  • Immunology (52.01%)
  • Human leukocyte antigen (27.59%)
  • Internal medicine (21.91%)

What were the highlights of her more recent work (between 2018-2021)?

  • Immunology (52.01%)
  • Allergy (14.55%)
  • Intensive care medicine (16.56%)

In recent papers she was focusing on the following fields of study:

Elizabeth J. Phillips mostly deals with Immunology, Allergy, Intensive care medicine, Internal medicine and Drug allergy. Her study in Delayed hypersensitivity, Human leukocyte antigen, Immune system, Antigen and T cell is done as part of Immunology. Her studies in Delayed hypersensitivity integrate themes in fields like ELISPOT and Drug.

Her studies deal with areas such as Pharmacogenomics and Allele as well as Human leukocyte antigen. Her Allergy research also works with subjects such as

  • Adverse drug reaction most often made with reference to Antibiotics,
  • Penicillin that connect with fields like Cephalosporin. Her research on Internal medicine often connects related topics like Gastroenterology.

Between 2018 and 2021, her most popular works were:

  • Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans. (335 citations)
  • Immediate Hypersensitivity to Polyethylene Glycols and Polysorbates: More Common Than We Have Recognized. (60 citations)
  • Maintaining Safety with SARS-CoV-2 Vaccines. (47 citations)

In her most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

Elizabeth J. Phillips mainly investigates Allergy, Internal medicine, Immunology, Penicillin and T cell. Her Allergy research integrates issues from Adverse effect and Intensive care medicine. Her Internal medicine research incorporates themes from Endocrinology and T cell reactivity.

Her study in the field of Hla genotype is also linked to topics like Oxcarbazepine. Her T cell research also works with subjects such as

  • T-cell receptor most often made with reference to Cytotoxic T cell,
  • Antigen, which have a strong connection to Immunotherapy and Melanoma. She works mostly in the field of Delayed hypersensitivity, limiting it down to topics relating to Young adult and, in certain cases, Human leukocyte antigen.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

HLA-B*5701 Screening for Hypersensitivity to Abacavir

Simon Mallal;Elizabeth Phillips;Giampiero Carosi;Jean-Michel Molina.
The New England Journal of Medicine (2008)

1870 Citations

Fulminant Myocarditis with Combination Immune Checkpoint Blockade

Douglas B. Johnson;Justin M. Balko;Margaret L. Compton;Spyridon Chalkias.
The New England Journal of Medicine (2016)

1052 Citations

Predisposition to abacavir hypersensitivity conferred by HLA-B*5701 and a haplotypic Hsp70-Hom variant

Annalise M. Martin;David Nolan;Silvana Gaudieri;Silvana Gaudieri;Coral Ann Almeida.
Proceedings of the National Academy of Sciences of the United States of America (2004)

519 Citations

Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

Evan Phillips;Oula Penate-Medina;Pat B. Zanzonico;Richard D. Carvajal.
Science Translational Medicine (2014)

443 Citations

Randomized Controlled Trial of Chlorhexidine Gluconate for Washing, Intranasal Mupirocin, and Rifampin and Doxycycline Versus No Treatment for the Eradication of Methicillin-Resistant Staphylococcus aureus Colonization

Andrew E. Simor;Andrew E. Simor;Elizabeth Phillips;Allison McGeer;Allison McGeer;Ana Konvalinka.
Clinical Infectious Diseases (2007)

367 Citations

High Sensitivity of Human Leukocyte Antigen-B*5701 as a Marker for Immunologically Confirmed Abacavir Hypersensitivity in White and Black Patients

Michael Saag;Rukmini Balu;Elizabeth Phillips;Philip Brachman.
Clinical Infectious Diseases (2008)

360 Citations

Predisposition to nevirapine hypersensitivity associated with HLA-DRB1*0101 and abrogated by low CD4 T-cell counts

Annalise M Martin;David Nolan;Ian James;Paul Cameron.
AIDS (2005)

358 Citations

T cells from patients with Parkinson’s disease recognize α-synuclein peptides

David Sulzer;Roy N. Alcalay;Francesca Garretti;Lucien Cote.
Nature (2017)

355 Citations

Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

David A. Ostrov;Barry J. Grant;Yuri A. Pompeu;John Sidney.
Proceedings of the National Academy of Sciences of the United States of America (2012)

353 Citations

Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans.

Jose Mateus;Alba Grifoni;Alison Tarke;John Sidney.
Science (2020)

348 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Elizabeth J. Phillips

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 95

Munir Pirmohamed

Munir Pirmohamed

University of Liverpool

Publications: 81

Dean J. Naisbitt

Dean J. Naisbitt

University of Liverpool

Publications: 53

Jamie Rossjohn

Jamie Rossjohn

Monash University

Publications: 49

Pascal Demoly

Pascal Demoly

University of Montpellier

Publications: 44

Bjoern Peters

Bjoern Peters

La Jolla Institute For Allergy & Immunology

Publications: 40

B. Kevin Park

B. Kevin Park

University of Liverpool

Publications: 37

Simon Mallal

Simon Mallal

Vanderbilt University Medical Center

Publications: 35

Douglas B. Johnson

Douglas B. Johnson

Vanderbilt University Medical Center

Publications: 33

Ulrich Wiesner

Ulrich Wiesner

Cornell University

Publications: 33

Werner J. Pichler

Werner J. Pichler

University Hospital of Bern

Publications: 33

Daniela Weiskopf

Daniela Weiskopf

La Jolla Institute For Allergy & Immunology

Publications: 30

Dan M. Roden

Dan M. Roden

Vanderbilt University Medical Center

Publications: 29

Mariana Castells

Mariana Castells

Brigham and Women's Hospital

Publications: 26

Silvana Gaudieri

Silvana Gaudieri

Vanderbilt University Medical Center

Publications: 25

Neil H. Shear

Neil H. Shear

Sunnybrook Health Science Centre

Publications: 23

Something went wrong. Please try again later.